Research map: Methyl-CpG-binding protein 2 facilitates progression of metabolic dysfunction-associated fatty liver disease via lactylation

Back to the article

Papers in this map

  1. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · Michael I. Love · 2014 · 104531 citations · Cited by this paper
  2. Meetings and Courses · 2026 · Related
  3. KEGG: Kyoto Encyclopedia of Genes and Genomes · Minoru I. Kanehisa · 2000 · 40352 citations · Cited by this paper
  4. A rare case of emphysematous liver abscess · 2026 · Related
  5. The Gene Ontology Resource: 20 years and still GOing strong · Consortium, The Gene Ontology · 2018 · 5267 citations · Cited by this paper
  6. Meetings and Courses · 2026 · Related
  7. Metabolic regulation of gene expression by histone lactylation · Di Zhang · 2019 · 4375 citations · Cited by this paper
  8. Non-physiological renoportal anastomosis during liver transplantation in a patient with Yerdel grade 4 portal vein thrombosis · 2026 · Related
  9. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease · Mary Eugenia Rinella · 2023 · 2555 citations · Cited by this paper
  10. Neutrophil percentage-to-albumin and carbohydrate antigen 19-9 stratified score predicts postoperative recurrence in biliary tract cancer · 2026 · Related
  11. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis · Quentin Mark Anstee · 2013 · 1780 citations · Cited by this paper
  12. Tumor component proportion determines the prognosis of patients with combined hepatocellular-cholangiocarcinoma · 2026 · Related
  13. Genetic compensation induced by deleterious mutations but not gene knockdowns · Andrea Rossi · 2015 · 1334 citations · Cited by this paper
  14. Exosome-delivered miR-769-3p promotes malignant progression of hepatocellular carcinoma via ALKBH5-dependent m6A modification · 2026 · Related
  15. Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States · Michael Charlton · 2011 · 1116 citations · Cited by this paper
  16. Yttrium-90 downstages giant hepatocellular carcinoma to resectable size · 2026 · Related
  17. Molecular Actions of PPARα in Lipid Metabolism and Inflammation · Nadia Bougarne · 2018 · 911 citations · Cited by this paper
  18. Timing of endoscopic retrograde cholangiopancreatography in acute cholangitis: A cohort study in Colombia · 2026 · Related
  19. Changing epidemiology, global trends and implications for outcomes of NAFLD · Vincent Wai‐Sun Wong · 2023 · 750 citations · Cited by this paper
  20. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma · Zijian Yang · 2023 · 595 citations · Cited by this paper
  21. MAFLD: How is it different from NAFLD? · Cameron Gofton · 2022 · 423 citations · Cited by this paper
  22. Lipogenesis inhibitors: therapeutic opportunities and challenges · Battsetseg Batchuluun · 2022 · 408 citations · Cited by this paper
  23. MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis · Jelena Mann · 2009 · 403 citations · Cited by this paper
  24. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis · Hyunsoo Rho · 2023 · 398 citations · Cited by this paper
  25. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells · Lianhong Pan · 2022 · 391 citations · Cited by this paper
  26. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease · Sanjaya Kumar Satapathy · 2015 · 373 citations · Cited by this paper
  27. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome · Christie M. Buchovecky · 2013 · 251 citations · Cited by this paper
  28. MeCP2 links heterochromatin condensates and neurodevelopmental disease · Charles H. Li · 2020 · 212 citations · Cited by this paper
  29. Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease · Ruxin Gao · 2023 · 180 citations · Cited by this paper
  30. Therapeutic management of metabolic dysfunction associated steatotic liver disease · Jing Zeng · 2024 · 129 citations · Cited by this paper
  31. Exercise-induced endothelial Mecp2 lactylation suppresses atherosclerosis via the Ereg/MAPK signalling pathway · Yanan Wang · 2023 · 110 citations · Cited by this paper
  32. Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021 · Ziwei Guo · 2025 · 94 citations · Cited by this paper
  33. Unlocking the multifaceted molecular functions and diverse disease implications of lactylation · Fengyang Jing · 2024 · 93 citations · Cited by this paper
  34. Rett syndrome – biological pathways leading from MECP2 to disorder phenotypes · Friederike Ehrhart · 2016 · 91 citations · Cited by this paper
  35. Role of lactate and lactate metabolism in liver diseases (Review) · Shun Zhong Yao · 2024 · 81 citations · Cited by this paper
  36. Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis · Liangqi Chen · 2024 · 76 citations · Cited by this paper
  37. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis · Jingjing Yang · 2013 · 65 citations · Cited by this paper
  38. MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons · Yi Liu · 2024 · 61 citations · Cited by this paper
  39. The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology · Kazem Nejati‐Koshki · 2023 · 32 citations · Cited by this paper

Source: OpenAlex (CC0)